POLARIS GROUPPOLARIS GROUPPOLARIS GROUP

POLARIS GROUP

No trades
See on Supercharts

6550 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Polaris Group engages in the research and development of biotechnology drugs. Its business activities include exploration and confirmation of new drug targets, design and improvement of large and small molecule new drugs, planning and execution of clinical trials, and manufacture and quality control of pharmaceutical drugs. It offers cancer treatment drugs, and contract development and manufacturing organization services for biopharmaceutical industries. The company was founded on February 9, 2006 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
6550 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company